Odyssey Therapeutics, Inc.
ODTX
$20.73
$0.010.05%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Net Income | -28.02% | 0.45% | |||
| Total Depreciation and Amortization | -17.68% | -9.85% | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 388.98% | -14.56% | |||
| Change in Net Operating Assets | -51.53% | -36.07% | |||
| Cash from Operations | -0.72% | -6.25% | |||
| Capital Expenditure | -541.38% | 84.03% | |||
| Sale of Property, Plant, and Equipment | 234.52% | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -1,009.85% | -0.14% | |||
| Cash from Investing | -1,007.29% | 1.98% | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -31.43% | 31.43% | |||
| Issuance of Common Stock | 4,867,616.67% | 177.02% | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -- | -- | |||
| Cash from Financing | 146.09% | 142.00% | |||
| Foreign Exchange rate Adjustments | -67.80% | -65.22% | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -57.15% | -35.50% | |||